The proposed revisions maintain the Board’s original position that telemedicine care will be held to the same standards as in-person care. However, the changes would allow the evaluation that precedes diagnosis or treatment to be conducted remotely if the provider is able to conduct a remote consult on-par with an in-person examination.
Under the proposed changes to the prescription guidelines, providers would be able to issue prescriptions if the provider is able to obtain the “threshold information” required to make an accurate diagnosis. This is a change from the original guidelines that necessitated in-person examinations prior to prescribing outside of on-call and similar scenarios, and gives providers latitude on using telemedicine to prescribe medication.
More articles on telemedicine:
Leveraging mHealth to reduce hospital readmissions
Anthem, UnitedHealthcare offer telemedicine coverage in Nevada
Telemonitoring reduces readmissions by 44%, increases ROI, finds Geisinger study
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.